Starpharma Holdings (Starpharma Holdings) Total Liabilities : $6.35 Mil (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Starpharma Holdings Total Liabilities?

Starpharma Holdings's Total Liabilities for the quarter that ended in Dec. 2023 was $6.35 Mil.

Starpharma Holdings's quarterly Total Liabilities increased from Dec. 2022 ($11.22 Mil) to Jun. 2023 ($11.59 Mil) but then declined from Jun. 2023 ($11.59 Mil) to Dec. 2023 ($6.35 Mil).

Starpharma Holdings's annual Total Liabilities increased from Jun. 2021 ($8.36 Mil) to Jun. 2022 ($12.50 Mil) but then declined from Jun. 2022 ($12.50 Mil) to Jun. 2023 ($11.59 Mil).

Starpharma Holdings Total Liabilities Historical Data

The historical data trend for Starpharma Holdings's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starpharma Holdings Total Liabilities Chart

Starpharma Holdings Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Liabilities

Get a 7-Day Free Trial

4.49

5.35

8.36

12.50

11.59

Starpharma Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial															8.76	12.50	11.22	11.59	6.35

Starpharma Holdings Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Starpharma Holdings's Total Liabilities for the fiscal year that ended in Jun. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	9.713	+	(1.846	+	2.7755575615629E-17
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0.032)
	=	11.59

Total Liabilities	=	Total Assets (A: Jun. 2023 )	-	Total Equity (A: Jun. 2023 )
	=	34.957	-	23.366
	=	11.59

Starpharma Holdings's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	4.722	+	(1.579	+	0.045
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	6.35

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	29.406	-	23.06
	=	6.35

Starpharma Holdings Total Liabilities Related Terms

Thank you for viewing the detailed overview of Starpharma Holdings's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Starpharma Holdings (Starpharma Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starpharma Holdings Ltd (OTCPK:SPHRF) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

SPHRY:USA PQ6:Germany SPL:Australia

Address

4-6 Southampton Crescent, Abbotsford, Melbourne, VIC, AUS, 3067

Website

https://www.starpharma.com

Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications. It focuses on the development of VivaGel for the management and prevention of bacterial vaginosis and as a condom coating and VIRALEZE an antiviral nasal spray.